nicergoline has been researched along with haloperidol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Battaglia, A; Bertè, F; Canonico, PL; Feletti, F; Pamparana, F; Richelmi, P; Vairetti, M | 1 |
| Battaglia, A; Bertè, F; Carfagna, N; Luigi Canonico, P; Richelmi, P; Vairetti, M | 1 |
| Battaglia, A; Bertè, F; Canonico, PL; Ferrigno, A; Richelmi, P; Vairetti, M | 1 |
4 other study(ies) available for nicergoline and haloperidol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Haloperidol-induced changes in glutathione and energy metabolism: effect of nicergoline.
Topics: Adenosine Triphosphate; Animals; Antipsychotic Agents; Brain; Cerebellum; Cerebral Cortex; Energy Metabolism; Glutathione; Haloperidol; Liver; Male; Neostriatum; Nicergoline; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1999 |
Antioxidant properties of MDL and MMDL, two nicergoline metabolites, during chronic administration of haloperidol.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Brain; Glutathione; Haloperidol; Liver; Male; Nicergoline; Rats; Rats, Sprague-Dawley | 2002 |
Nicergoline reverts haloperidol-induced loss of detoxifying-enzyme activity.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Glutathione Peroxidase; Glutathione Reductase; Haloperidol; Male; Nicergoline; Oxidoreductases; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2004 |